H3 Biomedicine publishes comprehensive analysis of RNA splicing factor genes in multiple types of cancer

April 4, 2018 Leave a comment 2,384 Views

Novel findings underscore promise of H3 Biomedicine’s first-in-class splicing factor modulator H3B-8800 currently in Phase 1 clinical trial for patients with hematologic cancers and splicing factor...

RNA-Seq Blog Transcriptome Research & Industry News

Tag Archives: H3 Biomedicine

H3 Biomedicine publishes comprehensive analysis of RNA splicing factor genes in multiple types of cancer

Whole blood RNA sequencing approach to identifying RNA biomarkers for COVID-19

Analysis and visualization of spatial transcriptomic data

scDART-seq reveals distinct m6A signatures and mRNA methylation heterogeneity in single cells

A novel prognostic model based on single-cell RNA sequencing data for hepatocellular carcinoma

Dual RNA-Seq analysis of SARS-CoV-2 correlates specific human transcriptional response pathways directly to viral expression

ICRNASA 2022 – International Conference on RNA Sequencing and Analysis

New data suggest he percepta GSC RNA sequencing-based risk-stratification test can help accelerate timely treatment for patients with early-stage lung cancer